Beaphar One Dose Wormer for Small Dogs and Puppies, 100 mg Film Coated Tablets

البلد: المملكة المتحدة

اللغة: الإنجليزية

المصدر: VMD (Veterinary Medicines Directorate)

العنصر النشط:

Nitroscanate

متاح من:

Elanco Europe Ltd

ATC رمز:

QP52AX01

INN (الاسم الدولي):

Nitroscanate

الشكل الصيدلاني:

Film-coated tablet

نوع الوصفة الطبية :

AVM-GSL - Authorised Veterinary Medicine – General Sales List

المجموعة العلاجية:

Dogs

المجال العلاجي:

Anthelmintic

الوضع إذن:

Expired

تاريخ الترخيص:

2000-06-30

خصائص المنتج

Revised: November 2018
AN: 00829/2018
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Beaphar One Dose Wormer for Small Dogs and Puppies, 100 mg film-coated
tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active ingredient
mg/tablet
Nitroscanate
100
For a full list of excipients see section 6.1.
3.
PHARMACEUTICAL FORM
Film coated tablet.
Yellowish-white to light beige round, film coated tablet, with
‘kx’ imprinted on one
side and ‘CGV’ on the other.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
A broad spectrum anthelmintic for use in small dogs and puppies up to
6 kg. It is
highly effective in a single dose against common canine nematodes and
cestodes
in the UK: _Toxocara canis, Toxascaris leonina, Ancylostoma caninum,
Uncinaria _
_stenocephala, Taenia ovis, Taenia hydatigena, Taenia pisiformis _and
_Dipylidium _
_caninum._
At the recommended dosage, the product gives limited control of
_Echinococcus _
_granulosus._
4.3
CONTRAINDICATIONS
Do not administer if your dog is sick or recovering from an illness.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
Revised: November 2018
AN: 00829/2018
Page 2 of 4
4.5
SPECIAL PRECAUTIONS FOR USE
i.
Special precautions for use in animals
Do not repeat treatment if vomiting occurs shortly after dosing.
ii.
Special precautions to be taken by the person administering the
medicinal
product to animals
Tablets are film coated and should not be broken or divided.
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
The tablets, when administered as recommended are unlikely to cause
vomiting.
Do not repeat treatment if vomiting occurs shortly after dosing.
4.7
USE DURING PREGNANCY, LACTATION OR LAY
Not contraindicated in pregnant animals. Nursing females should be
treated at the
same time and as frequently as puppies up to 12 weeks of age (i.e. 2,
4, 6, 8,
12 weeks).
4.8
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
None known.
4.9
AMOUNT(S) TO B